Stopped: Management decision
The purpose of this Post-Market Clinical Follow-Up (PMCF) study is to continuously assess the visual performance and safety of TOTAL30 Sphere and TOTAL30 for Astigmatism contact lenses in a real-world setting across a broad variety of patients through routine clinical practices.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Distance visual acuity with study lenses at baseline
Timeframe: Baseline
Distance visual acuity with study lenses at 1-year follow-up
Timeframe: Year 1
Incidence of corneal infiltrative events
Timeframe: Up to Year 1
Incidence of microbial keratitis
Timeframe: Up to Year 1